Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer.
about
Novel Molecular Markers for Breast CancerAberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerThe quiescent cellular state is Arf/p53-dependent and associated with H2AX downregulation and genome stabilityMMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancerRole of chaperone mediated autophagy (CMA) in the degradation of misfolded N-CoR protein in non-small cell lung cancer (NSCLC) cellsIron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesisThe Arf-inducing transcription factor Dmp1 encodes a transcriptional activator of amphiregulin, thrombospondin-1, JunB and Egr1Haploinsufficient tumor suppressor genes.Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform.Sirt3, mitochondrial ROS, ageing, and carcinogenesis.SIRT3 and SIRT4 are mitochondrial tumor suppressor proteins that connect mitochondrial metabolism and carcinogenesis.Critical roles of DMP1 in human epidermal growth factor receptor 2/neu-Arf-p53 signaling and breast cancer development.Dmp1α inhibits HER2/neu-induced mammary tumorigenesis.Signal transduction involving the dmp1 transcription factor and its alteration in human cancerDMP1β, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancerRegulation of murine hematopoietic stem cell quiescence by Dmtf1MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1.Human DMTF1β antagonizes DMTF1α regulation of the p14(ARF) tumor suppressor and promotes cellular proliferation.Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion.Emerging roles of DMP1 in lung cancerPrognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer.Role of DMP1 and its future in lung cancer diagnostics.Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer.Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancerAberrant expression of cyclin D1 in cancer.Clinical applications of mouse models for breast cancer engaging HER2/neu.Regulation of MnSOD enzymatic activity by Sirt3 connects the mitochondrial acetylome signaling networks to aging and carcinogenesis.Haplo-insufficiency: a driving force in cancer.Implications of endoplasmic reticulum stress, the unfolded protein response and apoptosis for molecular cancer therapy. Part I: targeting p53, Mdm2, GADD153/CHOP, GRP78/BiP and heat shock proteins.Alterations of p63 and p73 in human cancers.Transcription factors that interact with p53 and Mdm2Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α.Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.Virus-induced gene silencing of the RPC5-like subunit of RNA polymerase III caused pleiotropic effects in Nicotiana benthamiana.Haploinsufficiency of Tumor Suppressor Genes is Driven by the Cumulative Effect of microRNAs, microRNA Binding Site Polymorphisms and microRNA Polymorphisms: An In silico Approach.Dmp1 physically interacts with p53 and positively regulates p53's stability, nuclear localization, and function.p53 loss does not permit escape from BrafV600E-induced senescence in a mouse model of lung cancer.Genomic alterations of ground-glass nodular lung adenocarcinoma.
P2860
Q26753160-C01BFD5F-0F4F-41ED-B3CD-060E7B281862Q26773907-F9BCFBC2-4B4F-4DBB-A2DA-6CC42A3C3FE3Q26864097-6A9D10E6-9285-40BD-8DC1-B5FB6DE2FBD5Q28250940-3083D82E-A8B3-40B2-9DC0-694143D1CA69Q28477214-8FFBF847-508B-470E-86CE-B1A7CA009DABQ28576835-69E7FD0A-49E1-43B8-8D1E-455C90DCC626Q28854364-3FD482F0-AAE4-49BA-8B78-83BB7868131DQ33864922-1DD11780-875E-42CF-ABF0-BE9BC731C910Q33903965-2BF1F717-8A28-4672-8D37-5FF041C0675BQ34048030-23E97E50-ED7A-4DF1-B5C5-1470AA688FB0Q34053211-9980A173-3A2F-481A-B202-2AF9F4BD2AFDQ34373638-211614B8-52A3-415F-AB1B-8762C4A05871Q34778229-B416FE71-08E4-4ED0-A3A3-AA93A44D3853Q35035710-3BF47B48-15BA-4321-9E2F-4ED75AACAFA6Q35181050-F1D8F6DB-6B54-429D-8FE1-DB854A8E6EE9Q35434433-8A838B0C-87F6-48A7-8D9D-35D1FB93E7A1Q35623644-57065D5E-8B02-43BE-B9A9-78F6F13E2A29Q36140715-03187929-F7B5-41A6-879E-816E7C0305BCQ36394792-187EF19B-A83E-43FF-B61E-F69714F067E6Q36954381-E013FBD4-F798-4468-84ED-C3FF15171592Q37044618-AA7900F1-ED30-42ED-B401-27A5A0982233Q37093018-F56D173D-3F5B-4E63-9890-5D322860DFA5Q37111920-4A43E35A-7159-486A-BCAA-42A1968C8839Q37218223-7AE4B28D-04E0-409E-8594-F530E5A70D6CQ37306546-8FA227E0-E15A-4DC5-8830-4CA9EAE2A4F0Q37580471-7A1698EF-B4B6-404C-9D53-C26576D0A183Q37607675-26B8BB2F-AC2A-4638-9991-7562CC793EAEQ37617643-4D4106F1-0BAD-4993-AD08-E6F2536B61F7Q37815124-B06F71D5-0AE9-4105-9ACD-61012FED336DQ38089906-0DD732D7-7CD6-40A1-A38F-E3788CDC051DQ38247152-385E86B6-BB20-47D8-8A7E-9AF97F5EC0A1Q38541481-CDC85529-07B2-4720-AC2D-E722BADDE1FCQ38838490-91CDF1EE-D321-41CE-99ED-E81AD201D0B0Q38935156-74343EFF-F623-4D79-8D8A-44DD5156D3C3Q40709355-32086231-B1A7-40E5-AEB6-E648CDB87CE2Q41932257-302111C7-2DF4-4DB2-8E84-B71BA8D4E44DQ42246401-77689D6D-023B-4EC6-BFA0-A4534F630973Q48026380-B3E7D30D-06E0-4276-A843-55CB1E04C2FEQ54209531-BAD0D39D-40D0-448E-A2D8-5388E0E64A06
P2860
Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer.
@en
type
label
Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer.
@en
prefLabel
Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer.
@en
P2093
P2860
P1433
P1476
Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer.
@en
P2093
Ali Mallakin
Donna P Frazier
Gregory A Hawkins
Kazushi Inoue
Lauren A Matise
Mark C Willingham
Mayur Choudhary
Pankaj Taneja
Ralph B D'Agostino
Takayuki Sugiyama
P2860
P304
P356
10.1016/J.CCR.2007.08.034
P577
2007-10-01T00:00:00Z